` Comparison: BAYRY vs SAN - Alpha Spread

BAYRY
vs
SAN

Over the past 12 months, BAYRY has significantly outperformed SAN, delivering a return of +68% compared to the SAN's 29% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BAYRY
SAN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BAYRY Intrinsic Value
HIDDEN
Show
SAN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Bayer AG
OTC:BAYRY
10.99 USD
Sanofi SA
PAR:SAN
76.39 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BAYRY, SAN

BAYRY
SAN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Bayer AG
Revenue
Sanofi SA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BAYRY, SAN

BAYRY
SAN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Bayer AG
OTC:BAYRY
Sanofi SA
PAR:SAN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BAYRY
58.8%
SAN
72.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Operating Margin

BAYRY
14.8%
SAN
21.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Net Margin

BAYRY
-7.9%
SAN
16.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

FCF Margin

BAYRY
7.5%
SAN
23.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROE

BAYRY
-12.5%
SAN
10.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROA

BAYRY
-3.4%
SAN
6%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROIC

BAYRY
8.4%
SAN
7.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

ROCE

BAYRY
8.8%
SAN
10%
LTM 3Y Avg 5Y Avg 10Y Avg
Bayer AG
Sanofi SA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BAYRY, SAN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BAYRY, SAN

Performance Gap Between BAYRY and SAN
HIDDEN
Show

Performance By Year
BAYRY, SAN

Loading
BAYRY
SAN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BAYRY to other stocks
ROG
Roche Holding AG
More expensive
vs BAYRY
AZN
AstraZeneca PLC
More expensive
vs BAYRY
NOVO B
Novo Nordisk A/S
More expensive
vs BAYRY
ZTS
Zoetis Inc
More expensive
vs BAYRY
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett